Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cell Mol Neurobiol
1999 Dec 01;196:745-57. doi: 10.1023/a:1006905106834.
Show Gene links
Show Anatomy links
Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ.
Eterović VA
,
Lu R
,
Eakin AE
,
Rodríguez AD
,
Ferchmin PA
.
???displayArticle.abstract???
1. Phencyclidine (PCP) is an inhibitor of the nicotinic acetylcholine receptor (AChR) with characteristics of an open-channel blocker. The location of PCP binding site on the AChR molecule is unknown. 2. PCP inhibits the AChR from electric organ with a higher potency than muscle AChR. To find the molecular basis of this difference, we expressed the two native and six hybrid receptors, and two receptors containing mutated mouse gamma subunits in Xenopus laevis oocytes. The inhibition of ACh-induced current in these receptors by PCP was studied using whole-cell voltage-clamp. All hybrid receptors generated robust ACh-induced currents, while incomplete receptors (gamma-less or delta-less) did not. 3. PCP potency was higher on hybrids containing Torpedo beta and gamma subunits regardless of the alpha and delta subunit origin. A mouse gamma subunit containing the asparagine 6' to the serine mutation in the M2 segment conferred a high sensitivity to PCP. 4. These results support the conclusion that the amino acid residues at the position 6' of the M2 segments contribute to the PCP potency difference between Torpedo and mouse receptors. 5. Another noncompetitive inhibitor of the AChR, the cembranoid eupalmerin acetate (EUAC), also inhibited the electric organ receptor with a somewhat higher potency than muscle AChR. However, the IC50 values for EUAC inhibition of hybrid receptors did not follow the pattern observed for PCP. Therefore, these two inhibitors interact differently with the AChR molecule.
Albuquerque,
Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane.
1980, Pubmed
Albuquerque,
Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane.
1980,
Pubmed
Arias,
Topology of ligand binding sites on the nicotinic acetylcholine receptor.
1997,
Pubmed
Blanton,
Probing the structure of the nicotinic acetylcholine receptor ion channel with the uncharged photoactivable compound -3H-diazofluorene.
1998,
Pubmed
Changeux,
Effects of chlorpromazine and phencyclidine on mouse C2 acetylcholine receptor kinetics.
1986,
Pubmed
Charnet,
An open-channel blocker interacts with adjacent turns of alpha-helices in the nicotinic acetylcholine receptor.
1990,
Pubmed
DiPaola,
Mapping the alpha-subunit site photolabeled by the noncompetitive inhibitor [3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor.
1990,
Pubmed
Donnelly-Roberts,
Binding sites for alpha-bungarotoxin and the noncompetitive inhibitor phencyclidine on a synthetic peptide comprising residues 172-227 of the alpha-subunit of the nicotinic acetylcholine receptor.
1991,
Pubmed
Eaton,
Differential effects of dimethyl sulfoxide on nicotinic acetylcholine receptors from mouse muscle and Torpedo electrocytes.
1997,
Pubmed
,
Xenbase
Eterovic,
Noncompetitive inhibitors of the acetylcholine receptor help paint a picture of its ion channel.
1995,
Pubmed
Eterović,
The ion channel of muscle and electric organ acetylcholine receptors: differing affinities for noncompetitive inhibitors.
1993,
Pubmed
,
Xenbase
Eterović,
Diterpenoids from Caribbean gorgonians act as noncompetitive inhibitors of the nicotinic acetylcholine receptor.
1993,
Pubmed
,
Xenbase
Francis,
Sensitivity to voltage-independent inhibition determined by pore-lining region of the acetylcholine receptor.
1998,
Pubmed
,
Xenbase
Giraudat,
The noncompetitive blocker [(3)H]chlorpromazine labels segment M2 but not segment M1 of the nicotinic acetylcholine receptor alpha-subunit.
1989,
Pubmed
Giraudat,
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine.
1986,
Pubmed
Giraudat,
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains.
1987,
Pubmed
Hann,
Characterization of cembranoid interaction with the nicotinic acetylcholine receptor.
1998,
Pubmed
,
Xenbase
Haring,
Species differences determine azido phencyclidine labeling pattern in desensitized nicotinic acetylcholine receptors.
1983,
Pubmed
Haring,
Localization of phencyclidine binding sites on alpha and beta subunits of the nicotinic acetylcholine receptor from Torpedo ocellata electric organ using azido phencyclidine.
1984,
Pubmed
Heidmann,
Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata.
1983,
Pubmed
Hucho,
The ion channel of the nicotinic acetylcholine receptor is formed by the homologous helices M II of the receptor subunits.
1986,
Pubmed
Karlin,
Explorations of the nicotinic acetylcholine receptor.
,
Pubmed
Karpen,
Cocaine, phencyclidine, and procaine inhibition of the acetylcholine receptor: characterization of the binding site by stopped-flow measurements of receptor-controlled ion flux in membrane vesicles.
1986,
Pubmed
Kotzyba-Hibert,
Aryldiazonium salts as photoaffinity labels of the nicotinic acetylcholine receptor PCP binding site.
1985,
Pubmed
Lurtz,
Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
1997,
Pubmed
Mosckovitz,
Localization of azidophencyclidine-binding site on the nicotinic acetylcholine receptor alpha-subunit.
1987,
Pubmed
Oberthür,
The reaction site of a non-competitive antagonist in the delta-subunit of the nicotinic acetylcholine receptor.
1986,
Pubmed
Oswald,
Mechanism of phencyclidine binding to the acetylcholine receptor from Torpedo electroplaque.
1984,
Pubmed
Oswald,
Multiple affinity states for noncompetitive blockers revealed by [3H]phencyclidine binding to acetylcholine receptor rich membrane fragments from Torpedo marmorata.
1983,
Pubmed
Papke,
Mechanisms of noncompetitive inhibition of acetylcholine-induced single-channel currents.
1989,
Pubmed
Pedersen,
Structure of the noncompetitive antagonist-binding site of the Torpedo nicotinic acetylcholine receptor. [3H]meproadifen mustard reacts selectively with alpha-subunit Glu-262.
1992,
Pubmed
Revah,
The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel.
1990,
Pubmed
Tamamizu,
Mutations in the M1 region of the nicotinic acetylcholine receptor alter the sensitivity to inhibition by quinacrine.
1995,
Pubmed
,
Xenbase
White,
The hydrophobic photoreagent 3-(trifluoromethyl)-3-m-([125I] iodophenyl) diazirine is a novel noncompetitive antagonist of the nicotinic acetylcholine receptor.
1991,
Pubmed
White,
Agonist-induced changes in the structure of the acetylcholine receptor M2 regions revealed by photoincorporation of an uncharged nicotinic noncompetitive antagonist.
1992,
Pubmed
Yoshii,
Equilibrium properties of mouse-Torpedo acetylcholine receptor hybrids expressed in Xenopus oocytes.
1987,
Pubmed
,
Xenbase
Yu,
Single-channel properties of mouse-Torpedo acetylcholine receptor hybrids expressed in Xenopus oocytes.
1991,
Pubmed
,
Xenbase
